Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers

ABSTRACT: In this study, the efficacy of pembrolizumab in patients with locally advanced, irresectable dMMR colorectal cancer will be assessed.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2396381 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR